| Literature DB >> 33212316 |
Kiandokht Keyhanian1, Raffaella Pizzolato Umeton2, Babak Mohit3, Vahid Davoudi4, Fatemeh Hajighasemi5, Mehdi Ghasemi6.
Abstract
Since the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a growing body of evidence indicates that besides common COVID-19 symptoms, patients may develop various neurological manifestations affecting both the central and peripheral nervous systems as well as skeletal muscles. These manifestations can occur prior, during and even after the onset of COVID-19 general symptoms. In this Review, we discuss the possible neuroimmunological mechanisms underlying the nervous system and skeletal muscle involvement, and viral triggered neuroimmunological conditions associated with SARS-CoV-2, as well as therapeutic approaches that have been considered for these specific complications worldwide.Entities:
Keywords: Coronavirus disease 2019 (COVID-19); Encephalitis; Guillain-Barré syndromes; Myelitis; Neuroimmunity; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Year: 2020 PMID: 33212316 PMCID: PMC7647896 DOI: 10.1016/j.jneuroim.2020.577436
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478